Showing 74 of 74on this page. Filters & sort apply to loaded results; URL updates for sharing.74 of 74 on this page
The Piro Lito Lab | Memorial Sloan Kettering Cancer Center
The Piro Lito Lab: KRAS-mutant lung cancer | Memorial Sloan Kettering ...
The Piro Lito Lab: Ben Sang, PhD | Memorial Sloan Kettering Cancer Center
The Piro Lito Lab: Yaohua (Jenny) Xue | Memorial Sloan Kettering Cancer ...
The Piro Lito Lab: Chuanchuan Li | Memorial Sloan Kettering Cancer Center
The Piro Lito Lab: Dongsung Kim, PhD | Memorial Sloan Kettering Cancer ...
The Piro Lito Lab: Feng Hu, PhD | Memorial Sloan Kettering Cancer Center
Piro Lito – Targeting RAS 2025
The Piro Lito Lab | Gerstner Sloan Kettering Graduate School of ...
College of Human Medicine - Dr. Piro Lito
Piro Lito Martha Solomon LianSheng Li Rasmus Hansen
The Piro Lito Lab: Yonina Murciano-Goroff MD, DPhil | Gerstner Sloan ...
Piro Lito, MD, PhD | Damon Runyon Cancer Research Foundation
VIDEO: Piro Lito, 'A "new" old approach to inactivate RAS' - The Cancer ...
Piro Lito, MD, PhD - MSK Thoracic Medical Oncologist
Dr. Piro Lito, MD, PhD, Oncology | New York, NY | WebMD
Piro Lito: Breaking the Wall to inactivate mutant KRAS for the ...
Researchers Uncover New Findings about KRAS, an Important Protein in ...
2021 Annual Report: After Four Decades, a Breakthrough for Lung Cancer ...
Potential Drug Shows Promise Targeting a Range of KRAS-Driven Cancers ...
How Four Decades of Research Led to an Important Advance in Lung Cancer ...
Why KRAS Inhibitors for Lung Cancer Stop Working (and What Can Be Done ...
MSK Researchers Are Learning Why Some Patients Develop Resistance to ...
Promising Results from the First-Ever Trial of a Drug that Blocks ...
A Potential Advance Against RAS Gene-Driven Cancers | Memorial Sloan ...
Highlights from the EACR-Boehringer Ingelheim 2025 Conference: Drugging ...
FDA Approves Oncomine Dx Express Test for Tumor Profiling and as ...
Powering Breakthroughs in Targeted Cancer Therapies | MSK Giving
The Josie Robertson Investigators Program | Memorial Sloan Kettering ...
"癌王"患者的曙光！Daraxonrasib即将进入临床研究的最后阶段医药新闻-ByDrug-一站式医药资源共享中心-医药魔方
MSK Awards & Appointments June 2022 | Memorial Sloan Kettering Cancer ...
Cancer Discovery on Twitter: "In the Spotlight: Suppressing Nucleotide ...
Prof Elizalde’s Magic Cancer Research at CONICET – For Better Science
College of Human Medicine - News & Features
Daraxonrasib Moves Toward Phase 3 in RAS-Mutant Pancreatic Cancer After ...
Table 1 from Large Cell Neuroendocrine Carcinoma of the Lung: Clinico ...
Table 1 from Effects of Co-occurring Genomic Alterations on Outcomes in ...
The New England Journal of Medicine - Recent studies provide new ...
The Drug-Induced Degradation of Oncoproteins: An Unexpected Achilles ...
泛 KRAS 抑制剂禁用致癌信号传导和肿瘤生长,Nature - X-MOL
Thérapies ciblant les cellules cancéreuses | Boehringer Ingelheim
Frontiers | A Comparative Analysis of Individual RAS Mutations in ...
Amazing experience at the 5th Ras Initiative Symposium on the latest ...
Frontiers | Molecular Characterization and Clinical Relevance of RNA ...
Comprehensive Analysis of Pyroptosis-Related Genes and Tumor ...
Anti-tumor activity of MRTX1133 in human tumor xenografts Maximal ...
Modeling Pancreatic Cancer with Patient-Derived Organoids Integrating ...
Molecular mechanisms of cancer pathology (PI Trerotola) | Center for ...
Insights into how adeno-squamous transition drives KRAS inhibitor ...
Cancers | Special Issue : New Findings in Targeting Cancer Proteins
Frontiers | Contents in tumor-educated platelets as the novel biosource ...
Comprehensive Pan-Cancer Analyses of Pyroptosis-Related Genes to ...
New publication in Cancer Discovery! – Gen Cell Dis
Identifying cancer cell‐secreted proteins that activate cancer ...
Frontiers | A Novel Pyroptosis-Associated Long Non-coding RNA Signature ...
Highlights in Cancer Research: December 2025 - The Cancer Researcher
